SAB Biotherapeutics Balance Sheet (2020-2026)

Reported Financials

SAB Biotherapeutics Quarterly Balance Sheet

Periods 23 quarters

Latest Jun 2026

SAB Biotherapeutics reported total assets of $238.21M and total liabilities of $23.43M for the quarter ended Jun 2026, up 690.6% year over year. This balance sheet covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation		3.22M	3.76M	4.51M	5.38M	6.28M			8.99M	9.91M	11.87M	12.91M	13.85M	14.57M	15.32M	16.08M	16.82M	17.52M	18.12M	18.75M
Receivables - AccuredAcc. Int. Receivables											0.19M	0.23M	0.10M	0.10M	0.02M		0.56M	0.95M	1.60M	1.84M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	10.75M	33.21M	22.41M	16.62M	8.33M	15.05M	13.06M	7.77M	2.43M	56.57M	14.03M	17.24M	9.20M	8.90M	5.64M	3.69M	29.42M	10.50M	20.52M	8.27M
Receivables - NetNet Receivables		8.01M	11.79M	9.61M	12.94M	5.56M	0.76M	0.36M
Receivables		8.01M	11.79M	9.61M	12.94M	5.56M	0.76M	0.36M
Prepaid Assets	0.10M	2.64M	2.99M	1.77M	0.91M	1.49M	1.21M	0.87M	0.70M	2.34M	2.70M	2.03M	2.04M	2.98M	3.42M	3.59M	1.84M	3.51M	3.84M	3.46M
Current Assets	0.77M	50.19M	37.18M	28.00M	22.18M	22.10M	15.03M	9.01M	3.13M	58.91M	46.95M	39.58M	32.54M	23.79M	16.30M	9.31M	113.28M	101.05M	112.78M	107.94M
Non-Current Assets
Construction in Progress		4.61M				0.31M	0.33M
Property, Plant & Equipment (Net)		24.31M	24.97M	24.84M	24.03M	23.25M	22.37M	21.53M	20.62M	19.74M	17.90M	16.92M	16.08M	15.37M	14.61M	13.86M	13.11M	13.31M	13.81M	14.23M
Long-Term Investments	116.16M										1.24M						50.61M	46.89M	110.24M	105.35M
Other Non-Current Assets		13.10M
Non-Current Assets	116.16M	30.95M	31.30M	31.40M	30.33M	28.81M	27.64M	26.44M	25.21M	25.03M	24.42M	22.31M	21.26M	20.40M	21.82M	20.82M	70.17M	71.76M	135.69M	130.27M
Assets	116.93M	81.14M	68.49M	59.41M	52.51M	50.90M	42.67M	35.44M	28.34M	83.94M	71.37M	61.89M	53.80M	44.20M	38.12M	30.13M	183.45M	172.81M	248.47M	238.21M
Liabilities
Current Liabilities
Accounts Payables		12.46M	11.86M	9.86M	10.24M	9.92M	8.19M	5.93M	5.30M	6.69M	5.17M	5.05M	6.88M	5.47M	6.06M	7.09M	6.85M	6.58M	5.39M	7.21M
Notes Payables		1.80M	1.04M	0.28M	0.03M	0.77M	0.44M	0.11M	0.54M	1.05M	0.84M	0.62M		0.28M	0.14M
Payables		14.25M	12.90M	10.14M	10.26M	10.69M	8.63M	6.04M	5.84M	7.74M	6.01M	5.67M	6.88M	5.75M	6.19M	7.09M	6.85M	6.58M	5.39M	7.21M
Accumulated Expenses	0.32M							1.10M	1.10M
Other Accumulated Expenses		0.28M	0.34M	0.34M	0.25M	0.51M	0.20M	0.27M	0.21M	0.48M	0.64M	0.22M	1.70M	0.52M	0.74M	0.81M	1.62M	0.85M	1.01M	1.60M
Current Leases		0.16M	0.15M	0.14M	0.14M	0.13M	0.13M	0.13M	0.13M	0.13M	0.13M	0.14M	0.14M	0.14M	0.15M	0.15M	0.15M	0.15M	0.16M	0.16M
Current Taxes			0.09M
Current Deferred Revenue		0.10M					2.94M	2.89M	1.63M	1.32M	0.38M	0.11M	0.11M
Total Current Liabilities	0.32M	26.46M	19.27M	16.39M	17.10M	14.99M	13.67M	11.01M	9.21M	10.81M	8.30M	7.55M	8.82M	7.98M	9.65M	10.68M	10.79M	10.68M	9.85M	11.71M
Non-Current Liabilities
Capital Leases		3.76M	3.73M	3.69M	3.66M	3.63M	3.60M	3.49M	3.45M	3.42M	3.38M	3.35M	3.31M	3.28M	3.24M	3.20M	3.16M	3.12M	3.08M	3.04M
Non-Current Debt						0.54M
Convertible Debt						0.54M	0.54M	0.54M
Non-Current Deffered Revenue	-4.22M
Preferred Stock Liabilities	116.15M
Operating Leases		1.65M	1.36M	1.06M	0.76M	0.36M	0.23M	0.09M		0.64M	0.55M	0.78M	0.68M	0.58M	2.47M	2.26M	2.04M	1.88M	2.17M	1.45M
Other Non-Current Liabilities	5.53M	10.72M	2.87M	1.14M	0.36M	0.32M	0.24M	0.60M	0.42M	11.77M	6.31M	4.09M	4.08M	6.39M	1.35M	1.98M	2.38M	5.63M	6.12M	7.23M
Total Non-Current Liabilities	76.32M	31.87M	24.36M	21.15M	21.53M	19.53M	18.03M	15.13M	12.66M	14.87M	12.24M	11.68M	12.81M	11.84M	15.36M	16.13M	15.99M	15.68M	15.10M	16.20M
Total Liabilities	81.85M	42.59M	27.23M	22.29M	21.88M	19.85M	18.27M	15.73M	13.08M	26.64M	18.55M	15.77M	16.89M	18.23M	16.71M	18.11M	18.37M	21.32M	21.22M	23.43M
Shareholder's Equity
Total Debt		1.80M	1.04M	0.28M	0.03M	1.31M	0.44M	0.11M	0.54M	1.05M	0.84M	0.62M		0.28M	0.14M
Common Equity	35.08M	38.55M	41.26M	37.12M	30.62M	31.06M	24.40M	19.72M	15.26M	57.30M	52.82M	46.12M	36.90M	25.97M	21.41M	12.02M	165.07M	151.50M	227.25M	214.78M
Liabilities and Shareholders Equity	116.93M	81.14M	68.49M	59.41M	52.51M	50.90M	42.67M	35.44M	28.34M	83.94M	71.37M	61.89M	53.80M	44.20M	38.12M	30.13M	183.45M	172.81M	248.47M	238.21M
Treasury Shares			0.55M	0.55M	0.55M	0.05M	0.55M	0.55M	0.55M	-0.05M	-0.05M	-0.05M	-0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M
Retained Earnings	-9.29M	-29.13M	-28.14M	-32.92M	-40.00M	-47.87M	-55.22M	-62.10M	-67.21M	-90.06M	-95.10M	-102.42M	-112.80M	-124.17M	-129.40M	-139.50M	-94.03M	-110.89M	-129.80M	-152.30M
Preferred Shares										5.00	5.00	5.00	5.00	5.00	5.00	5.00	67.00		62.00

SAB Biotherapeutics Balance Sheet API

Pull SAB Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SABS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "SABS", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=SABS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

SAB Biotherapeutics SABS Balance Sheet (2020-2026)

SAB Biotherapeutics Quarterly Balance Sheet

SAB Biotherapeutics Balance Sheet API

Create an account

Sign In

Reset Password